NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-198-2012-0-DE-09 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF DE EP 13753475.6 Issued
NCI E-198-2012-0-FR-10 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF FR EP 13753475.6 Issued
NCI E-198-2012-0-GB-11 MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF GB EP 13753475.6 Issued
NINDS E-023-2014-0-EP-08 Insulin-Like Growth Factor Mimetics For Use In Therapy EP National Stage 15708639.8 Abandoned
NHLBI E-254-2014-0-US-01 Genome-Wide Detection of Dnase I Hypersensitive Sites US 62/118,574 Abandoned
NCI E-191-2009-0-JP-09 Akt Phosphorylation at SER473 as an Indicator for Taxane-Based Chemotherapy JP DIV 2015-030517 Abandoned
NICHD E-347-2013-0-US-03 Software Coding/module Which Allows Intelligent Navigation Of The Fetal Heart US National Stage 14/422,335 Abandoned
NCI E-267-2016-1-US-01 Synthetic Self-assembling Peptide Antagonists Of Human CCR3 For The Treatment Of Inflammatory Diseases US 62/117,486 Abandoned
NCI E-052-2013-0-US-03 Use Of Argon As A Tissue Fixation Preservative US National Stage 14/422,062 9714409 Issued PDF
NCI E-258-2014-0-US-01 Cabozantinib Immunotherapy US 62/117,216 Abandoned
NIAID E-222-2012-0-US-07 Use Of P47 From Plasmodium Falciparum (PFS47) Or Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission US National Stage 14/421,964 Abandoned
NIDDK E-260-2012-0-US-05 Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids US National Stage 14/421,732 10457978 Issued PDF
NCI E-198-2012-0-US-06 Mesothelin Domain-Specific Monoclonal Antibodies and Use Thereof US National Stage 14/421,599 9409992 Issued PDF
NCI E-267-2016-0-US-01 Synthetic Self-assembling Peptide Antagonists Of Human CCR3 For The Treatment Of Inflammatory Diseases US 62/115,880 Abandoned
NIAID E-076-2015-1-US-01 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION US 62/116,021 Abandoned
NIAID E-222-2012-0-BR-03 Use Of P47 From Plasmodium Falciparum (PFS47) Or A Plasmodium Vivax (PVS47) As A Vaccine Or Drug Screening Targets For The Inhibition of Human Malaria Transmission BR National Stage BR112015003184-6 Abandoned
NCI E-031-2014-0-EP-04 PCSK9 VACCINE AND METHODS OF USING THE SAME EP National Stage 15708062.3 Issued
NCI E-031-2014-0-CH-06 PCSK9 VACCINE AND METHODS OF USING THE SAME CH EP 15708062.3 Issued
NCI E-031-2014-0-GB-09 PCSK9 VACCINE AND METHODS OF USING THE SAME GB EP 15708062.3 Issued
NCI E-031-2014-0-FR-08 PCSK9 VACCINE AND METHODS OF USING THE SAME FR EP 15708062.3 Issued
NCI E-031-2014-0-DE-07 PCSK9 VACCINE AND METHODS OF USING THE SAME DE EP 15708062.3 Issued
NCI E-031-2014-0-US-03 A Virus-like Display Vaccine For Inducing Autoantibodies To A PCSK9 Peptide US National Stage 15/118,143 10279019 Issued PDF
NIDDK E-260-2012-0-FR-07 Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids FR EP 13753962.3 Issued
NIDDK E-260-2012-0-DE-06 Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids DE EP 13753962.3 Issued
NIDDK E-260-2012-0-GB-08 Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids GB EP 13753962.3 Issued
NIDDK E-260-2012-0-IE-09 Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids IE EP 13753962.3 Issued
NCI E-031-2014-0-PCT-02 PCSK9 VACCINE AND METHODS OF USING THE SAME PCT PCT PCT/US2015/015408 Expired
NINDS E-089-2015-0-US-01 TEMPORAL PERFUSION MAPPING TO IDENTIFY BLOOD FLOW ABNORMALITIES US 62/114,951 Abandoned
NCATS E-040-2015-0-US-01 BENZENESULFONAMIDE UPREGULATORS OF NPC1 FOR NEIMANN-PICK DISEASE AND OTHER LYSOSOMAL STORAGE DISORDERS US 62/114,840 Abandoned
NIAID E-255-2016-0-PCT-02 CD-4 Mimetic Small Molecules Sensitize Human Immunogenicity Virus To Vaccine-elicited Antibody PCT PCT PCT/US2015/015182 Expired
NCI E-065-2015-0-US-01 Griffithsin Mutants US 62/114,217 Abandoned
NHLBI E-037-2011-0-JP-07 Development Of A Novel HDL Based Hydrophobic Drug Delivery System Using Amphipathic Peptides JP National Stage 2015526671 Pending
NCI E-079-2016-0-PCT-02 Biomarkers for Assessing Cancer Patients for Treatment PCT PCT PCT/US2015/015074 Expired
NINDS E-081-2008-2-AU-06 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems AU DIV 2015200569 Issued
NCI E-090-2014-2-CA-03 Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer CA National Stage 2938971 Issued
NCI E-090-2014-2-AU-02 Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer AU National Stage 2015214189 Issued
NCI E-090-2014-2-NO-10 Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer NO EP 15705869.4 Issued
NCI E-090-2014-2-ES-07 Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer ES EP 15705869.4 Issued
NCI E-090-2014-2-SE-11 Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer SE EP 15705869.4 Issued
NCI E-090-2014-2-GB-09 Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer GB EP 15705869.4 Issued
NCI E-090-2014-2-DE-06 Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer DE EP 15705869.4 Issued
NCI E-090-2014-2-FR-08 Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer FR EP 15705869.4 Issued
NCI E-090-2014-2-EP-04 Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer EP National Stage 15705869.4 Issued
NCI E-090-2014-2-US-05 Aza-Epoxy-Guaiane Derivatives and Treatment of Cancer US National Stage 15/116,887 9676788 Issued PDF
NCI E-090-2014-2-PCT-01 Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer PCT PCT COMB PCT/US2015/014601 Expired
NIDDK E-231-2012-0-US-04 Capillary Viscometer And Multiscale Pressure Differential Measuring Device US National Stage 14/419,914 Abandoned
NCI E-057-2012-0-US-04 Discovery Of Novel Inhibitors Of HIV-1 Integrase That Can Be Used For Treatment Of Retrovial Infection Including AIDS US DIV 14/615,203 Abandoned
NCI E-057-2012-0-US-03 Discovery Of Novel Inhibitors Of HIV-1 Integrase That Can Be Used For Treatment Of Retrovial Infection Including AIDS US National Stage 13/957,715 Abandoned
NCI E-234-2014-1-EP-06 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF EP National Stage 15746399.3 Issued
NCI E-234-2014-1-MX-01 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF MX DIV MX/A/2020/000309 Issued